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A B S T R A C T
Background: Migrants may be underimmunised and at higher risk of vaccine-preventable diseases, yet there has
been no comprehensive examination of what policies are currently implemented across Europe targeting child
and adult migrants. We analysed vaccination policies for migrants in 32 EU/EEA countries and Switzerland.
Methods: Using framework analysis, we did a comparative analysis of national policies and guidelines pertaining
to vaccination in recently arrived migrants through a systematic guideline and literature review and by ap-
proaching national experts.
Results: Six (18.8%) of 32 countries had comprehensive policies specific to the vaccination of migrants (two
focused only on child migrants, four on both adults and children). Nineteen (59.4%) countries applied their
national vaccination schedule for migrant vaccinations, predominantly focusing on children; and five (15.6%)
countries had circulated additional migrant-specific resources to relevant health-care providers. In six (18.8%)
countries, policies on migrant vaccination focused on outbreak-specific vaccines only. In ten (31.3%) countries,
policies focused on priority vaccinations, with polio being the vaccine most commonly administered and het-
erogeneity noted in vaccines recommended to adults, adolescents, and children. Eighteen (56.3%) countries
recommended that an individual should be considered as unvaccinated where vaccination records were missing,
and vaccines re-administered. Nine (28.1%) countries reported that specific vaccinations were mandatory.
Conclusion: There is considerable variation in policies across Europe regarding approaches to vaccination in
adult and child migrants, and a lack of clarity on optimum ways forward, what vaccines to offer, with a need for
robust research in this area. More emphasis must be placed on ensuring migrant-specific guidance is dis-
seminated to front-line healthcare professionals to improve vaccine delivery and uptake in diverse migration
populations across the region.
1. Introduction
Migrants within the European Union (EU) may represent an under-
immunised group, with implications for outbreaks of vaccine-pre-
ventable diseases [1]. Outbreaks of measles and hepatitis A have been
documented in migrant populations in Europe [2,3], and diseases in-
cluding poliomyelitis remain endemic in some migrant sending coun-
tries [4]. Migrants in the EU and European Economic Erea (EEA) are a
diverse group, including both internal EU migrants – moving from one
country in Europe to another – and external non-EU migrants. Although
the role of migrants in epidemics of vaccine-preventable diseases is
unclear, mainly due to poor data collection in this area, the current
multi-country measles epidemic in the EU/EEA has involved EU mi-
grants moving from and between countries with large epidemics [5].
Large numbers of recently arrived migrants to the EU may have an
uncertain vaccination status, including incomplete vaccination history
and/or missing documentation of previous vaccinations, with implica-
tions for health-care providers and how to approach catch-up vacci-
nation [6]. In a cohort of 2126 asylum-seeking children to Denmark
30% were considered not to be immunised in accordance with the
Danish schedule, with underimmunisation particularly high in adoles-
cent migrants (aged 10–17 years) [7]. Strategies and approaches to
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engaging migrant populations in vaccination are not clear due to the
lack of high quality studies assessing vaccination implementation [8].
A recent report has highlighted wide disparities in access to
healthcare and vaccination across Europe, with undocumented (irre-
gular migrants) in particular unable to access free vaccination because
of administrative barriers and lack of entitlement to free health services
including vaccination services [9]. This is despite the fact that ensuring
high levels of coverage is a key priority of the European Vaccine Action
Plan [10], in which all countries have committed to eliminating en-
demic measles and rubella (> 95% coverage with the measles mumps
rubella vaccine), controlling hepatitis B infection, and sustaining polio-
free status. Innovations in service provision to ensure hard-to-reach
groups, including migrants, access vaccination services remains an
important component to reducing vaccine-preventable diseases in
Europe.
However, current approaches to the vaccination of migrants have
not been well documented to date, and it is acknowledged that there are
additional challenges in ensuring equitable access to vaccines in diverse
and mobile migrant populations [9,11]. The ongoing refugee crisis has
facilitated renewed dialogue around approaches to the screening and
vaccination of recently arrived migrants for infectious diseases. The
World Health Organization (WHO), United Nations High Commissioner
for Refugees, and the United Nations Children's Fund recommended in
2015 that migrants in the WHO European Region should be vaccinated
soon after arrival in accordance with the immunisation schedule of the
receiving country in which they intend to stay for more than a week
[11], and the European Centre for Disease Prevention and Control
(ECDC) is currently developing guidance on approaches to vaccine-
preventable diseases in newly arrived migrants [12]. However, there
has to date been no comprehensive examination of what policies or
guidelines are currently implemented across Europe, or how they
compare across countries. In order to facilitate the harmonisation of
vaccination policies across Europe and identify best practice, a clear
understanding of the different policies and of the key gaps or incon-
sistencies in such policies is needed [13,14]. We therefore did a com-
parative analysis of policies and guidelines in EU/EEA countries and
Switzerland relating to the provision of vaccinations to recently arrived
migrants to identify common approached.
2. Methods
We documented and analysed vaccination policies for migrants in
32 EU/EEA countries, and Switzerland. The policy analysis was guided
by Bardach's health policy framework [15,16], and consisted of a
comparative analysis of policies or guidance for vaccination in migrants
across European countries. Primary and secondary data sources were
used to identify evidence for the analysis. Key migrant groups included
recently arrived migrants (foreign born, in the host country< 10
years), refugees (granted asylum), asylum seekers (awaiting a decision
on their asylum application in the host country), and undocumented
migrants (without necessary authorisation or documents required
under host country's immigration regulations). Primary data were ob-
tained through contacting national experts in each country, who were
asked to provide both relevant health policy documents. Secondary
data consisted of relevant health policy documents and guidelines
around vaccination in migrants, which were obtained through a sys-
tematic search of the literature and published papers from relevant
health bodies such as Ministries of Health.
2.1. Approaching national experts
National experts for the included EU/EEA countries and Switzerland
were identified through the network of the European Study Group for
Infections in Travellers and Migrants (ESGITM), which contributes to
activities in the field of travel and migration related infectious diseases
as part of the European Society of Clinical Microbiology and Infectious
Diseases (ESCMID). Experts were also identified through relevant
publications and key meetings over the last 5 years (e.g. the European
Congress of Clinical Microbiology and Infectious Diseases [ECCMID]).
Between December 2016 and May 2017, we emailed experts in the
following 32 countries: Austria, Belgium, Bulgaria, Cyprus, Croatia,
Czech Republic, Denmark, Estonia, Finland, France, Germany, Greece,
Hungary, Iceland, Ireland, Italy, Latvia, Liechtenstein, Lithuania,
Luxembourg, Malta, the Netherlands, Norway, Poland, Portugal,
Romania, Slovakia, Slovenia, Spain, Sweden, Switzerland and the
United Kingdom (UK). National experts were asked to provide docu-
ments relating to national policies or guidelines on vaccination in mi-
grants, with a key focus on national guidelines and definitions, man-
datory vaccinations, outbreak specific guidance, priority vaccinations,
and incomplete vaccination records. Non-respondents were contacted
either by e-mail or phone twice in an effort to include all 32 countries.
Where documents were provided in a language other than English, they
were translated as needed.
2.2. Secondary data collection and analysis
Expert input was complemented by the identification of secondary
data on health policies or guidelines across European countries through
a systematic search of the literature. First, we searched PubMed and
Google Scholar using terms relevant to migrants and vaccinations, in-
cluding “vaccination”, “immunisation”, “vaccine preventable diseases”,
“immunisation”, “migrants”, “refugees”, “European Union”, and
“health policy” between inception and June 20, 2017. Additional lit-
erature reporting policies or guidance on vaccination in migrants was
also identified through internet searches using relevant terms for each
specific country, and hand searching through health policy documents
and relevant national policy websites (e.g. for Ministries of Health).
2.3. Data analysis
Once the relevant data sources had been collated, we utilised fra-
mework analysis to synthesise relevant content on policies or guidance
for vaccination in migrants across the included countries. Our policy
analysis framework focused on key topics including national guidelines
and definitions, mandatory vaccinations, outbreak specific guidance,
priority vaccinations, and catch-up vaccination in the absence of com-
plete vaccination records. Relevant policies or guidance were extracted
and analysed for each country for each of the key framework themes.
3. Results
3.1. National guidelines and definitions
We identified guidance and policy documents for all 32 countries
through our database, internet, and hand searches and received re-
sponses from experts in 30 EU/EEA countries regarding national or
regional guidelines on vaccination in migrants. Using this two-pronged
approach, we therefore collated policies and guidance from all 32
countries under study.
We identified significant variation in policies and guidelines for
vaccination in migrants across the EU/EEA (Table 1). Six (18.8%) of 32
countries had specific vaccination guidelines for migrants, two of which
applied only to child migrants and four to both child and adult mi-
grants; we found that some of these guidelines were very comprehen-
sive in terms of approaches to catch-up vaccination in adults and child
migrants, and other were not. Five (15.6%) of 32 countries had circu-
lated migrant-specific resources to relevant health-care providers. 19
(59.4%) of 32 countries apply their national vaccination plan for vac-
cination in migrants, and two (6.3%) countries used the International
Organization for Migration (IOM) handbook with recommendations for
vaccination in migrants [17].
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3.2. Administration of vaccinations to adults, adolescents, and children
There was considerable heterogeneity across countries regarding
which vaccines should be administered to adults and child migrants.
Ten (31.3%) countries in total had national guidance or which stated
that specific vaccinations should be prioritised for migrants (Fig. 1).
Polio was the most frequently reported priority vaccine given to re-
cently arrived migrants, but vaccination for hepatitis B – for example –
was not being considered. Fig. 1 highlights that there was considerable
heterogeneity between what vaccines are recommended to adult, ado-
lescent, and child migrants.
3.3. Outbreak-specific recommendations
Six (18.8%) countries reported having specific guidelines or policies
in place regarding outbreak-specific vaccinations for migrants. These
guidelines differed in content, but in general provided information to
health-care providers in recognising certain infectious or epidemic
diseases and a name to contact in case of an outbreak among refugees/
migrants. One country recommended meningococcal vaccination when
an outbreak is identified through the Ministry of Health's surveillance
system [18,19]. In another country, a mobile medical team is re-
sponsible in certain areas for administering immunisations to adult
migrants who have not been vaccinated in the case of an infectious
disease outbreak [20].
3.4. Uncertain vaccination status
In 18 (56.3%) of 32 countries policies, guidelines, and/or resources
stated that a person should be considered as unvaccinated where vacci-
nation records are missing. In five countries a catch-up immunisation
document was available to guide vaccination in migrants with missed
vaccinations or a lack of records [20–24]. However, the approach to
determine vaccination status varied across countries. For example, oral
reporting of vaccination in children was not accepted as proof of vacci-
nation status in most countries. In one country oral reporting of vacci-
nation status was considered to be sufficient, and where there was un-
certainty about the vaccination status children are then considered
unvaccinated [25,26]. In another country, children below 5 years of age
for whom vaccination records were lacking, are assumed to be un-
vaccinated and subsequently included in the childhood vaccination
programme using vaccination intervals based on the age of the child. In
this same country for children aged 5–17 years, DTaP-IPV/Hib primary
vaccine (DiTeKiPol/Act-Hib) is administered once then antibodies
against diphtheria and tetanus are measured 1 month later [27]. Specific
guidance exists regarding incomplete vaccinations for migrants from the
top three migrant-sending countries at the current time (Syria, Iraq, and
Afghanistan) where vaccination coverage was relatively high prior to
conflict but has since dropped [28]. This guidance recommends catch-up
vaccination in children born since conflicts began in these countries, with
reference to the likelihood that vaccination status may also be in-
complete in adults arriving from these countries and for whom catch-up
vaccination should also be considered [28]. For most countries, there is
no specific guidance available on how to approach catch-up vaccination
in adult migrants of uncertain vaccination status, but information on
priority vaccines in adult migrants was available for 10 countries (Fig. 1).
3.5. Serology testing prior to vaccination
Four (12.5%) countries recommend against serology testing prior to
vaccination for migrants with incomplete vaccinations or a lack of
documentation on previous vaccination [22,24–31]. The main reasons
Table 1
Policy and guidance on vaccination in migrants in EU/EEA countries.
Policy/guidance on vaccination in migrants Number of countries [n= 32] (%)
Specific national policy/guidance for migrant vaccination 6 (18.8%) (2 for child migrants only; 4 for adult and child migrants)
Migrant-specific resources are available for healthcare workers; but no national policy/guidelines 5 (15.6%)
National vaccination plan is used and/or “catch up” vaccination document is circulated 19 (59.4%)
IOM handbook [17] 2 (6.3%)
Fig. 1. Priority vaccines across EU/EEA countries for migrant children, adolescents, and adults in those countries reporting migrant-specific policies.
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noted in the guidance against serology testing included: that the in-
terpretation of serology tests is difficult (3 countries), serology is ex-
pensive (2 countries), false negative results often occur (1 country), and
that migrants can easily and safely be revaccinated (1 country). Two
(6.3%) countries, however, do recommend serology testing prior to
vaccination. For example, the guideline recommends hepatitis B ser-
ology testing at the health check on arrival to the country, performed as
part of screening for these infectious diseases [32]. Another country
recommended the approach that all migrant women of childbearing age
without a history of varicella infection should have their immunity
checked, and that women with negative serology should be vaccinated
[33].
3.6. Mandatory vaccination
We found considerable variations across EU/EEA countries in rela-
tion to whether vaccinations were mandatory or voluntary for migrants,
with nine (28.1%) countries reporting that specific vaccinations were
mandatory according to national policy. The definition and regulation
of ‘mandatory’ vaccination policies were not well described, nor were
consequences if vaccinations were refused. In most countries, guide-
lines did not stipulate that vaccinations were mandatory, though they
were considered highly recommended.
4. Discussion
4.1. Summary of key findings
There were striking variations in terms of policy and guidance re-
garding vaccination in migrants across EU/EEA countries, with six
(18.8%) of 32 countries having comprehensive policies specific to the
vaccination of migrants, of which 2 focused only on child migrants.
More than half of the countries applied their national vaccination
schedule for migrant vaccinations, which is a response advocated by
WHO and others [13]. In ten (31.3%) countries, policies focused on
priority vaccinations, with polio being the vaccine most commonly
administered and heterogeneity in which vaccines were recommended
to adults, adolescents, and children. Some countries reported migrant-
specific guidelines relating to outbreak-specific vaccine-preventable
diseases only, and substantial variation was found across countries re-
lating to whether vaccinations were mandatory. Our analysis found
differences across countries when migrant presented to a health service
with a missing or incomplete vaccination record, a common phenom-
enon in this group, with eighteen (56.3%) countries recommending that
an individual should be considered as unvaccinated where vaccination
records were missing, and vaccines re-administered.
4.2. Strengths and limitations
We aimed to provide a comprehensive examination of policies and
guidance on the vaccination of recently arrived migrants in EU/EEA
countries and Switzerland. Whilst we aimed to systematically search
the secondary literature as well as contact national experts in this field
in each European country, the field of vaccination among migrants is
moving quickly and policies and guidelines are dependent on political
context. Our policy, guideline, and literature search was done up to
May 2017, and we are aware that more guidelines could have been
published and circulated since this date; however, we have been in
dialogue with vaccination experts since May 2017 and are not aware of
anything significant that has been published and that would change our
overall key findings. There are also numerous regional or local level
policies or guidelines that may be implemented across Europe, as well
as unpublished documents, which were not identified through our re-
search.
4.3. Policy versus practice
It is not clear to what extent these policies, guidelines, and circu-
lated resources were implemented in practice. In a recent EU-EEA-wide
questionnaire survey, we found that implementation is considered by
experts to be poor, with few initiatives targeting migrants specifically,
and that adult migrants may be particularly excluded from catch-up
vaccination on or after arrival [34]. This survey also highlighted a lack
of clarity around what vaccinations should be given to adult and child
migrants. These shortfalls have been reported by others, noting that
high quality studies assessing vaccination implementation in migrant
populations are lacking with which to inform policy making in this area
[8].
4.4. Current shortfalls and next steps
The lack of national guidance around provision of basic care to
recently arrived migrants has been previously reported [35], and it is
well known that approaches to screening for infectious diseases in mi-
grants varies considerably across the EU/EEA [36]. Migrants, we know,
face multiple barriers to accessing healthcare on arrival to a host
country, including vaccinations. It may be that there is a need for
harmonisation of migrant vaccination approaches across European
transit and receiving countries, guided by existing recommendations
such as those produced by the IOM and others [17,35,37–39], involving
non-governmental organizations and statutory service providers, and
including some mechanism for monitoring and recording the delivery
and uptake of vaccines to migrants specifically. This was highlighted by
the European Parliament in January 2016, who called for health po-
licies and health systems in the WHO European Region to better ac-
knowledge migrants [39]. In light of increasingly restrictive health
policies across Europe [40] vaccinations must be provided free of
charge to high-risk groups, which aligns with European and interna-
tional recognition of migrants’ rights to health [41]. There are clear
clinical, public health, and human rights arguments for promoting ac-
cess to an acceptable level of free health care, including vaccination, to
migrants.
We report that vaccinations were mandatory for migrants in eight
(26.7%) countries, a finding supported by data from the Vaccine
European New Integrated Collaborative Effort (the VENICE project) –
initiated to improve and monitor vaccination programmes in Europe
[42]. VENICE data shows that compliance to vaccination programmes
in European countries without mandatory vaccination is high among
migrants and non-migrants [42], and they question to what extent
vaccinations should be mandatory, suggesting that this is an area that
needs warrants further discussion. There are numerous reasons mi-
grants may wish not to be vaccinated e.g. cultural beliefs and legal
reasons, such as seeking to avoid registration in a country which may
require them to claim asylum in that country [13] as well as significant
barriers to accessing care, and more robust research is needed to elu-
cidate the key concerns of migrants around vaccination uptake on ar-
rival to an EU/EEA country.
The ECDC vaccine schedule database allows comparison of vacci-
nation policies between countries, highlighting immunisation schedules
in all EU countries [43], but the database does not have data on vaccine
schedules for migrants specifically. More emphasis must be placed on
improving data collection around vaccine-preventable diseases in mi-
grants in the EU/EEA, to better understand the extent to which these
groups are both underimmunised and involved in outbreaks, so that
targeted programmes can be implemented in relevant groups. The
priority vaccines reported in guidelines in this policy analysis reflect
current ECDC recommendations that vaccinations be offered according
to national immunisation guidelines, with priority given to easily
transmitted and/or serious infectious diseases such as polio [38]. The
Canadian evidence-based guidelines on the vaccination of newly ar-
rived migrants is more extensive – and covers both adult and child
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migrants – giving priority to MMR, DTP, polio, varicella, hepatitis B and
tuberculosis. We have presented these guidelines in Table 2 to give a
clear overview of what EU/EEA countries could adopt in terms of catch-
up vaccination [37]. They recommend a full vaccination work up for a
recently arrived migrant to Canada, including MMR, DTP for all adults
as well as children with uncertain vaccination status, serological testing
and vaccination in adults for varicella, and adding hepatitis B vacci-
nation in specific adult and child migrant populations from high-burden
countries. The IOM has also recommended vaccination for recently
arrived migrants/refugees according the national schedule for the
country, with priority for protection against measles, rubella, diph-
theria, tetanus, pertussis, polio, Hib and hepatitis B [17]. Whilst such
guidance may be informative for harmonising approaches to vaccina-
tion in migrants, our data suggest that there remains a critical need now
to generate a comprehensive set of guidelines for the EU/EEA context
and – importantly – work towards uptake and implementation of gui-
dance at the national level across the EU/EEA targeting both child and
adult migrants in catch-up vaccination. This aligns with priorities of the
WHO European Vaccine Action Plan [10], that seek to reduce inequities
in access to vaccination in migrant populations in Europe. Strong pro-
motional campaigns and a commitment to improving access to primary
care – whilst being mindful of the different experiences that each EU
country has with respect to migration demographics and health-care
resources – will be crucial for improving the health status of recently
arrived migrants across Europe.
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Key points
∗ There is striking variation in policies relating to the vaccination of
recently arrived migrants across Europe. Six (18.8%) countries had
comprehensive guidance and regulations specific to the vaccination
of migrants, of which in 2 countries guidance only focused on child
migrants. It is not clear to what extent guidelines are applied in
practice.
∗ There is heterogeneity in approaches to priority vaccination in child,
adolescent, and adult migrants. Polio is the most commonly ad-
ministered vaccine and other vaccinations according to guidelines
analysed – for example hepatitis B – may not be considered.
∗ Differences were found across countries when migrant presented
with missing or incomplete vaccination records and a lack of clarity
in terms of how to approach catch-up vaccination
∗ There is a lack of clarity on optimum approaches to vaccination in
migrants, and a need for robust research and data collection in this
area to explore and assess what works best in terms of the im-
plementation of vaccination strategies in both child and adult mi-
grants.
∗ More emphasis must be placed on ensuring migrant-specific gui-
dance is disseminated to front-line healthcare professionals to im-
prove vaccine delivery and uptake in diverse migration populations
across the region.
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